MRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice

Hyperintense lesions on T2-weighted MR images of the brain, predominantly located in the basal ganglia, the brainstem and cerebellum, are a frequent finding in patients with neurofibromatosis type 1. Nature and significance of these lesions are still unknown so that the term 'unidentified bright objects' (UBOs) has been introduced to allow an unbiased description. We analyzed brain MRI scans of 31 children with definite diagnosis of neurofibromatosis type 1 according to the NIH criteria. High-intensity lesions on T2-weighted images were present in 86% of the patients. They did not correlate to other MRI findings such as optic pathway gliomas and were not indicative of intellectual impairment. Additionally, brain MR imaging of Nf1 knockout mice was performed to find out if similar abnormalities are present in this animal model. A total of 9 Nf1 knockout mice was examined on a dedicated animal MRI scanner at 4.7 Tesla but no evidence of high-signal intensity lesions on T2-weighted images was found. Therefore, the Nf1 mouse model seems to be unhelpful in providing further insights into the histological basis of hyperintense MRI abnormalities in NF1 patients.

[1]  Linda J. Schuerholz,et al.  Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. , 1996, American journal of medical genetics.

[2]  A. Barkovich,et al.  Evolution of white matter lesions in neurofibromatosis type 1: MR findings. , 1992, AJR. American journal of roentgenology.

[3]  M. Kaiser-Kupfer,et al.  NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. , 1990, Annals of internal medicine.

[4]  D. Shucard,et al.  The significance of MRI abnormalities in children with neurofibromatosis , 1989, Neurology.

[5]  N. Rosman,et al.  The brain in multiple neurofibromatosis (von Recklinghausen's disease): a suggested neuropathological basis for the associated mental defect. , 1967, Brain : a journal of neurology.

[6]  M. Nordlund,et al.  Neurofibromin Expression and Astrogliosis in Neurofibromatosis (Type 1) Brains , 1995, Journal of neuropathology and experimental neurology.

[7]  J. Charrow,et al.  Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history. , 1995, The Journal of pediatrics.

[8]  Robert A. Weinberg,et al.  Tumour predisposition in mice heterozygous for a targeted mutation in Nf1 , 1994, Nature Genetics.

[9]  P. Harper,et al.  Prenatal diagnosis and presymptomatic detection of neurofibromatosis type 1. , 1992, Journal of medical genetics.

[10]  V. Riccardi,et al.  Neurofibromatosis: Phenotype, Natural History and Pathogenesis , 1993 .

[11]  G. Ramsby,et al.  Neurofibromatosis Type 1: Magnetic Resonance Imaging Findings , 1993, Journal of child neurology.

[12]  E. Zackai,et al.  Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. , 1995, Radiology.

[13]  J. Charrow,et al.  Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. , 1994, The Journal of pediatrics.

[14]  N. Copeland,et al.  Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. , 1994, Genes & development.

[15]  N. Copeland,et al.  Neurofibromin-deficient fibroblasts fail to form perineurium in vitro. , 1995, Development.

[16]  Paul W. Frankland,et al.  A mouse model for the learning and memory deficits associated with neurofibromatosis type I , 1997, Nature Genetics.

[17]  R. Hughes,et al.  MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[18]  M. Denckla,et al.  Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force. , 1997, Neurology.

[19]  J. Steyaert,et al.  Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[20]  B. Moore,et al.  Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis , 1996, Neurology.

[21]  D. Louis,et al.  Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the nf1 optic pathway glioma task force , 1997 .

[22]  R. Cawthon,et al.  The neurofibromatosis type 1 gene. , 1993, Annual review of neuroscience.

[23]  S. Huson,et al.  A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. , 1989, Journal of medical genetics.

[24]  G. Scotti,et al.  Spontaneous involution of optic pathway lesions in neurofibromatosis type 1: serial contrast MR evaluation. , 1995, AJNR. American journal of neuroradiology.

[25]  R. Bryan,et al.  Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. , 1994, AJNR. American journal of neuroradiology.

[26]  G. Ramsby,et al.  Magnetic resonance imaging lesion analysis in neurofibromatosis type 1. , 1998, Archives of neurology.

[27]  M. Boguski,et al.  cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. , 1991, Genomics.

[28]  K. North,et al.  Specific learning disability in children with neurofibromatosis type 1 , 1994, Neurology.

[29]  C. Bazan,et al.  Spontaneous regression of optic glioma in a patient with neurofibromatosis , 1992, Neurology.